On September 7, 2022

Vermont adds hMPXV vaccination opportunities, but supply limited

Vermont has expanded eligibility for the hMPXV (human monkeypox virus) JYNNEOS vaccine to certain groups at higher risk of contracting the virus and has increased vaccination opportunities, but officials caution that vaccine supply is still limited at this time.

hMPXV can spread to anyone through close and often skin-to-skin contact with someone who is infected. At this time, gay, bisexual, and other men or trans people who have sex with men make up a high number of early cases and might be at higher risk of coming into contact with the virus.

Vermonters who identify as gay, bisexual, and other men or trans people who have sex with men, who had or expect to have more than one sexual partner are eligible for vaccination. Anyone who has had an exposure to hMPXV or possible exposure should also get vaccinated.

“We encourage anyone eligible to seek a vaccine appointment. Vaccination is an important way to protect yourself and prevent further spread of this virus,” said Health Commissioner Mark Levine. “We appreciate your patience as we continue working to make the vaccine available to as many eligible people as we can.”

Vermont currently has three confirmed cases of hMPXV. There are more than 18,000 cases in the U.S.

The Health Department has been working with health care providers and partners that already care for people at highest risk of exposure to hMPXV to vaccinate their patients. Starting Friday, Sept. 2, it is also offering limited appointments at its local health offices around the state.

The following providers have a limited supply of JYNNEOS vaccine, by appointment only:

  • Planned Parenthood – All locations (patients and non-patients accepted)
  • Community Health Centers of Burlington
  • University of Vermont Infectious Disease/Comprehensive Care Clinic
  • Health Department Local Health Offices. Call to schedule an appointment at 802-863-7200 ext. 2

The JYNNEOS vaccine is two doses, given four weeks apart.

Anyone with a rash that looks like hMPXV (which may look like pimples, blisters or sores) should talk to their health care provider, even if they don’t think they’ve had contact with someone who has hMPXV or call 2-1-1.

As of Sept. 1, Vermont has 266 vials of vaccine. The federal supply is determined by population of people considered at-risk and the number of new cases.

For more information, visit healthvermont.gov/hMPXV.

Do you want to submit feedback to the editor?

Send Us An Email!

Related Posts

Vt Legislature advances bill to ban toxic ‘forever chemicals’ from firefighting gear, dental floss, cleaning products

June 4, 2025
The Vermont Senate and House advance legislation (H.238) May 29 that would outlaw the use of toxic perfluoroalkyl and polyfluoroalkyl substances (PFAS) in firefighting gear, dental floss, cleaning products, and fluorine-treated containers—a critical step in reducing Vermonters’ exposure to these harmful substances. The Senate expanded the bill as passed by the House by adding a provision that…

To be continued…

June 4, 2025
A final compromise on education reform proved elusive late Friday, and at about 11 p.m., the Senate adjourned, followed by the House at about 11:30 p.m. As late as 10 p.m., legislative leaders were still hopeful that the six conferees (three House and three Senate members) could reach a deal sometime before midnight that would…

Nearing the end?

June 4, 2025
After passing several challenging bills in the last few weeks, the Vermont Legislature adjourned until June 16 due to an impasse over negotiations on our education transformation bill, H.454. Many other bills addressing housing, homelessness, healthcare, and several other major issues required compromises from both the House and the Senate in order to be passed…

Vermont gets $23 million from ongoing settlement with tobacco manufacturers

June 4, 2025
Attorney General Charity Clark announced last month that Vermont received a total of $23,132,483.92 from tobacco manufacturers under the tobacco Master Settlement Agreement (MSA). Annually, Vermont receives monies from tobacco manufacturers from the MSA, which resolved the state’s lawsuit filed in the 1990s. The settlement funds are credited to the state’s Tobacco Fund, and the…